Page last updated: 2024-11-06

lysergic acid diethylamide and Suicidal Ideation

lysergic acid diethylamide has been researched along with Suicidal Ideation in 3 studies

Lysergic Acid Diethylamide: Semisynthetic derivative of ergot (Claviceps purpurea). It has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is a potent hallucinogen, but the mechanisms of that effect are not well understood.
lysergic acid diethylamide : An ergoline alkaloid arising from formal condensation of lysergic acid with diethylamine.

Suicidal Ideation: A risk factor for suicide attempts and completions, it is the most common of all suicidal behavior, but only a minority of ideators engage in overt self-harm.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's3 (100.00)2.80

Authors

AuthorsStudies
Jones, GM1
Nock, MK1
Yang, KH1
Han, BH1
Palamar, JJ1
Jones, G1
Arias, D1
Nock, M1

Other Studies

3 other studies available for lysergic acid diethylamide and Suicidal Ideation

ArticleYear
MDMA/ecstasy use and psilocybin use are associated with lowered odds of psychological distress and suicidal thoughts in a sample of US adults.
    Journal of psychopharmacology (Oxford, England), 2022, Volume: 36, Issue:1

    Topics: Adolescent; Adult; Aged; Female; Hallucinogens; Health Surveys; Humans; Lysergic Acid Diethylamide;

2022
Past-year hallucinogen use in relation to psychological distress, depression, and suicidality among US adults.
    Addictive behaviors, 2022, Volume: 132

    Topics: Adult; Depression; Depressive Disorder, Major; Hallucinogens; Humans; Lysergic Acid Diethylamide; N-

2022
Associations between MDMA/ecstasy, classic psychedelics, and suicidal thoughts and behaviors in a sample of U.S. adolescents.
    Scientific reports, 2022, 12-19, Volume: 12, Issue:1

    Topics: Adolescent; Child; Cross-Sectional Studies; Hallucinogens; Humans; Lysergic Acid Diethylamide; Mesca

2022